Young AE, Manara AR, Burd DA. Intensive care management of the child with severe burns. Care of the Critically III 1995; 11:93–7.
Sheridan RL, Schnitzer JJ. Management of the high-risk pediatric burn patient. J Pediatr Surg 2001; 36:1308–12. [Crossref]
Meyers-Paal R, Blakeney P, Robert R, Murphy L, Chinkes D, Meyer W, et al. Physical and psychologic rehabilitation outcomes for pediatric patients who suffer 80% or more TBSA, 70% or more third degree burns. J Burn Care Rehabil 2000; 21:43–9. [Crossref]
Bull JP. Revised analysis of mortality due to burns. Lancet 1971; 2:1133–4. [Crossref]
Baux S, Mimoun M, Saade H. Burns in the elderly. Burns 1989; 15:239–40. [Crossref]
Tompkins RG, Burke JF, Schoenfeld D, Bondoc CC, Quinby WC Jr, Behringer GC, et al. Prompt eschar excision: a treatment system contributing to reduced burn mortality. A statistical evaluation of burn care at Massachusetts General Hospital (1974–1984). Ann Surg 1986; 204:272–81.
Thompson P, Herndon DN, Abston S, Rutan T. Effect of early excision of patients with major thermal injury. J Trauma 1987; 27:205–7. [Crossref]
Herndon DN, Barrow RE, Rutan RL, Rutan TC, Desai MH, Abston S. A comparison of conservative versus early excision. Therapies in severely burned patients. Ann Surg 1989; 209:547–53.
Engrav LH, Heimbach DM, Reus JL, Harnar TJ, Marvin JA. Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: a randomized prospective study. J Trauma 1983; 23:1001–4. [Crossref]
Hildreth MA, Herndon DN, Desai MH, Duke MA. Reassessing caloric requirements in pediatric burn patients. J Burn Care Rehabil 1988; 9:616–8. [Crossref]
Mochizuki H, Trocki O, Dominioni L, Alexander JW. Reduction of postburn hypermetabolism by early enteral feeding. Curr Surg 1985; 42:121–5.
Wolf SE, Rose JK, Desai MH, Mileski JP, Barrow RE, Herndon DN. Mortality determinants in massive pediatric burns. An analysis of 103 children with ≥80% TBSA burns (≥70% full-thickness). Ann Surg 1997; 225:554–65.
Ryan CM, Schoenfeld DA, Thorpe WP, Sheridan RL, Cassem EH, Tompkins RG. Objective estimates of the probability of death from burn injuries. N Engl J Med 1998; 338:362–6.
Pape SA, Skouras CA, Byrne PO. An audit of the use of laser Doppler imaging (LDI) in the assessment of burns of intermediate depth. Burns 2001; 27:233–9. [Crossref]
Clark JC, Reid WH, Gilmour WH, Campbell D. Mortality probability in victims of fire trauma: revised equation to include inhalation injury. Br Med J 1986; 292:1303–5.
Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350:485–7.
Bianchi DW. Fetal DNA in maternal plasma: the plot thickens and the placental barrier thins. Am J Hum Genet 1998; 62:763–4. [Crossref]
Bischoff FZ, Lewis DE, Simpson JL. Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update 2005; 11:59–67. [Crossref]
Lo YM, Tein MS, Pang CC, Yeung CK, Tong KL, Hjeim NM. Presence of donor-specific DNA in plasma of kidney and liver transplant recipients. Lancet 1998; 351:1329–30. [Crossref]
Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996; 2:1033–35. [Crossref]
Lei LI, Chan LY, Chan WY, Johnson PJ, Lo YM. Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) levels in patients with EBV-associated lymphoid malignancies. Br J Haematol 2000; 111:239–46. [Crossref]
Jen J, Wu L, Sidransky D. An overview on the isolation and analysis of circulating tumor DNA in plasma and serum. Ann NY Acad Sci 2000; 906:8–12.
Papadopoulou E, Davilas E, Sotiriou V, Koliopanos A, Aggelaki F, Dardoufas K, et al. Cell-free DNA and RNA in plasma as a new molecular marker for prostate cancer. Oncol Res 2004; 14:439–45.
Gautschi O, Bigosch C, Huegli B, Jermann M, Marx A, Chasse B, et al. Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol 2004; 22:4157–64. [Crossref]
Xie GS, Hou AR, Li LY, Gao YN, Cheng S. Quantification of plasma DNA as a screening tool for lung cancer. Chin Med J 2004; 117:1485–8.
Johnson PJ, Lo YM. Plasma nucleic acids in the diagnosis and management of malignant disease. Clin Chem 2002; 48:1186–93.
Sozzi G, Conte D, Leon ME, Cirincione R, Roz L, Ratcliffe C, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003; 21:3902–8. [Crossref]
Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000; 46:319–23.
Laktionov PP, Tamkovich SN, Rykova EY, Bryzgunova OE, Starikov AV, Kuznetsova NP, et al. Extracellular circulating nucleic acids in human plasma in health and disease. Nucleosides Nucleotides Nucleic Acids 2004; 23:879–83. [Crossref]
Lam NY, Rainer TH, Chan LY, Joynt GM, Lo DY. Time course of early and late changes in plasma DNA in trauma patients. Clin Chem 2003; 49:1286–91. [Crossref]
Rainer TH, Wong LK, Lam W, Yuen E, Lam NY, Metrewelli C, et al. Prognostic use of circulating plasma nucleic acid concentrations with acute stroke. Clin Chem 2003; 49:562–9. [Crossref]
Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998; 62:768–75. [Crossref]
Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991; 88:7272–80.
Tobiasen J, Hiebert J, Edlich R. Prediction of burn mortality. Surg Gynecol Obst 1982; 154:711–4.
Grad S, Ertel W, Keel M, Infanger M, Vonderschmitt DJ, Maly FE. Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after polytrauma and burn. Clin Chem Lab Med 1998; 36:379–83. [Crossref]